This session discusses optimal evaluation and treatment of patients with HPV-positive oropharynx cancer. In January 2018, AJCC 8 became the new staging system, with major differences for HPV-positive oropharynx cancers; the new staging, and its implications, will be discussed.

This educational session provides a comprehensive review of the safety, toxicity, and efficacy of currently available commercial immunotherapies combined with radiation therapy.

This session is a case-based education session with an expert panel encouraging audience participation.

As part of the ASTRO Refresher Course, this session will focus on new data and a treatment paradigm for patients with central nervous system tumors. Gliomas, brain metastases and common benign tumors will be covered.

This session will review the current standard treatment paradigm for all stages of lung cancer, with a special focus on radiation therapy, including the latest recommendations on stereotactic radiation therapy.  The session will also review the evolving treatment of metastatic lung cancer, especi

This session will update oncologists about the contemporary management of lymphoma and will address the following:

Pediatric radiation oncology represents a small but crucial part of clinical practice in radiation oncology.  As such the clinical practice, clinical research, and the application of newer technologies (such as proton therapy) are crucial in this setting and not likely readily available to all pr

There are at least 50 histologic sub-types of soft tissue sarcoma.

The breast educational session is an overview of modern breast radiation recommendations for both early and locally advanced breast cancer.  The session starts with an overview of early breast cancer management and treatment and highlight recent high impact journal articles to support current pra

The speaker will summarize the findings of 8 high-impact abstracts that were presented at the annual ASTRO meeting in September 2017. They were selected to consider the value they may offer radiation oncologists in the community.